{"id":"NCT02328404","sponsor":"Hayat Pharmaceutical Co. PLC","briefTitle":"The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)","officialTitle":"The Effect of Vitamin D Supplementation on Chromium Serum Levels and Insulin Resistance Among Overweight Jordanian Women With Polycystic Ovary Syndrome in Irbid","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-02","primaryCompletion":"2014-09","completion":"2014-12","firstPosted":"2014-12-31","resultsPosted":"2015-04-17","lastUpdate":"2016-08-04"},"enrollment":60,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Polycystic Ovary Syndrome","Hypovitaminosis D"],"interventions":[{"type":"DRUG","name":"50,000 IU vitamin D3","otherNames":["Biodal 50,000 IU","cholecalciferol 50,000 IU"]},{"type":"DRUG","name":"Placebo","otherNames":["Biodal 50,000IU"]}],"arms":[{"label":"vitamin D3 (Biodal 50,000 IU)","type":"ACTIVE_COMPARATOR"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a prospective double-blind, randomized, parallel-group, placebo-controlled trial designed to examine the effect of supplementation with 50,000 IU vitamin D3 for 3 months on Polycystic Ovary Syndrome (PCOS) prognosis, serum 25-Hydroxy Vitamin D (25(OH)D) level, serum chromium level, insulin resistance, and Body Mass Index (BMI), in 60 overweight Jordanian female patients diagnosed with PCOS and with hypovitaminosis D.","primaryOutcome":{"measure":"Ultrasound Examination of Number of Follicles and Ovarian Volume","timeFrame":"3 months","effectByArm":[{"arm":"Vitamin D3 (Biodal 50,000IU)","deltaMin":7,"sd":null},{"arm":"Placebo","deltaMin":0,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.001"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":15,"exclusionCount":13},"locations":{"siteCount":1,"countries":["Jordan"]},"refs":{"pmids":["33010974"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":["In-compliance , Withdral"]}}